532 related articles for article (PubMed ID: 7681374)
1. Carvedilol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.
McTavish D; Campoli-Richards D; Sorkin EM
Drugs; 1993 Feb; 45(2):232-58. PubMed ID: 7681374
[TBL] [Abstract][Full Text] [Related]
2. Carvedilol. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders.
Dunn CJ; Lea AP; Wagstaff AJ
Drugs; 1997 Jul; 54(1):161-85. PubMed ID: 9211087
[TBL] [Abstract][Full Text] [Related]
3. Pharmacology of carvedilol: rationale for use in hypertension, coronary artery disease, and congestive heart failure.
Ruffolo RR; Feuerstein GZ
Cardiovasc Drugs Ther; 1997 May; 11 Suppl 1():247-56. PubMed ID: 9211017
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic and pharmacodynamic comparison of controlled-release carvedilol and immediate-release carvedilol at steady state in patients with hypertension.
Henderson LS; Tenero DM; Baidoo CA; Campanile AM; Harter AH; Boyle D; Danoff TM
Am J Cardiol; 2006 Oct; 98(7A):17L-26L. PubMed ID: 17023228
[TBL] [Abstract][Full Text] [Related]
5. Carvedilol, a novel vasodilating beta-blocker with the potential for cardiovascular organ protection.
Feuerstein GZ; Ruffolo RR
Eur Heart J; 1996 Apr; 17 Suppl B():24-9. PubMed ID: 8733068
[TBL] [Abstract][Full Text] [Related]
6. Pharmacodynamic profile of carvedilol.
van Zwieten PA
Cardiology; 1993; 82 Suppl 3():19-23. PubMed ID: 8106159
[TBL] [Abstract][Full Text] [Related]
7. Carvedilol in ischaemic heart disease.
Prichard BN
Cardiology; 1993; 82 Suppl 3():34-9. PubMed ID: 8106163
[TBL] [Abstract][Full Text] [Related]
8. A new molecule with vasodilating and beta-adrenoceptor blocking properties.
Abshagen U
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S23-32. PubMed ID: 2454364
[TBL] [Abstract][Full Text] [Related]
9. Celiprolol. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in cardiovascular disease.
Milne RJ; Buckley MM
Drugs; 1991 Jun; 41(6):941-69. PubMed ID: 1715268
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the effects of carvedilol and nifedipine in patients with essential hypertension and non-insulin-dependent diabetes mellitus.
Albergati F; Paternó E; Venuti RP; Boeri D; Lombardo I; Semino S; Viviani GL; Adezati L
J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S86-9. PubMed ID: 1378156
[TBL] [Abstract][Full Text] [Related]
11. Lack of evidence for peripheral alpha(1)- adrenoceptor blockade during long-term treatment of heart failure with carvedilol.
Kubo T; Azevedo ER; Newton GE; Parker JD; Floras JS
J Am Coll Cardiol; 2001 Nov; 38(5):1463-9. PubMed ID: 11691524
[TBL] [Abstract][Full Text] [Related]
12. Vasodilatory action of carvedilol.
Sponer G; Strein K; Bartsch W; Müller-Beckmann B
J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S5-11. PubMed ID: 1378150
[TBL] [Abstract][Full Text] [Related]
13. Vasodilating beta-blockers in heart failure.
Raftery EB
Eur Heart J; 1995 Jul; 16 Suppl F():32-7. PubMed ID: 8521882
[TBL] [Abstract][Full Text] [Related]
14. Controlled-release carvedilol in the management of systemic hypertension and myocardial dysfunction.
Frishman WH; Henderson LS; Lukas MA
Vasc Health Risk Manag; 2008; 4(6):1387-400. PubMed ID: 19337551
[TBL] [Abstract][Full Text] [Related]
15. Artist® tablets (carvedilol) for hypertensive patients in Japan: results of a drug use survey.
Mori Y; Nishikawa Y; Iizuka T; Zenimura N; Matsumoto T; Hiramatsu K; Komiya M
Drugs R D; 2011; 11(2):171-90. PubMed ID: 21679007
[TBL] [Abstract][Full Text] [Related]
16. The preventative effects of vasodilating beta-blockers in cardiovascular disease.
Raftery EB
Eur Heart J; 1996 Apr; 17 Suppl B():30-8. PubMed ID: 8733069
[TBL] [Abstract][Full Text] [Related]
17. The use of carvedilol in elderly hypertensive patients.
Morgan TO; Anderson A; Cripps J; Adam W
Eur J Clin Pharmacol; 1990; 38 Suppl 2():S129-33. PubMed ID: 1974503
[TBL] [Abstract][Full Text] [Related]
18. Results of therapy with carvedilol, a beta-blocker vasodilator with antioxidant properties, in hypertensive patients.
Moser M; Frishman W
Am J Hypertens; 1998 Jan; 11(1 Pt 2):15S-22S. PubMed ID: 9503102
[TBL] [Abstract][Full Text] [Related]
19. Use of carvedilol in hypertension: an update.
Leonetti G; Egan CG
Vasc Health Risk Manag; 2012; 8():307-22. PubMed ID: 22661898
[TBL] [Abstract][Full Text] [Related]
20. [The benefits of carvedilol therapy in the treatment of patients with high cardiovascular risk].
Fi Z; Szentes V
Orv Hetil; 2016 Jun; 157(26):1029-34. PubMed ID: 27319383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
